NeurologyLive® Staff

home / authors / neurologylive-staff

Articles

New Alzheimer Association AUC, Patisiran Findings from AANEM, Evobrutinib findings from ECTRIMS

New Alzheimer Association AUC, Patisiran Findings from AANEM, Evobrutinib findings from ECTRIMS

NeurologyLive® Staff
October 20th 2018

Neurology News Network for the week of October 20, 2018.

Siponimod NDA Accepted, New Appropriate Use Criteria for Alzheimer Disease Diagnosis, Disease-Modifying Therapy

Siponimod NDA Accepted, New Appropriate Use Criteria for Alzheimer Disease Diagnosis, Disease-Modifying Therapy

NeurologyLive® Staff
October 13th 2018

Neurology News Network for the week of Oct. 12, 2018.

Never Events Common in Parkinson, Donepezil Fails to Prevent Psychosis, Helping Patients Live Well

Never Events Common in Parkinson, Donepezil Fails to Prevent Psychosis, Helping Patients Live Well

NeurologyLive® Staff
October 6th 2018

Neurology News Network for the week of October 6, 2018.

Galcanezumab Approved, Pimavanserin Safety Confirmed, Treating Augmentation in RLS, Genetics in Alzheimer

Galcanezumab Approved, Pimavanserin Safety Confirmed, Treating Augmentation in RLS, Genetics in Alzheimer

NeurologyLive® Staff
September 29th 2018

Neurology News Network for the week of September 28, 2018.

FDA Approves Fremanezumab, Behavioral Activation Therapy for MCI, Choosing DMTs for MS

FDA Approves Fremanezumab, Behavioral Activation Therapy for MCI, Choosing DMTs for MS

NeurologyLive® Staff
September 22nd 2018

Neurology News Network for the week of September 22, 2018.

XEN496 for KCNQ2 Epileptic Encephalopathy, the State of Acute Stroke Care, and Ocrelizumab's Success

XEN496 for KCNQ2 Epileptic Encephalopathy, the State of Acute Stroke Care, and Ocrelizumab's Success

NeurologyLive® Staff
September 15th 2018

Neurology News Network for the week of September 15, 2018.

<1
...
3334353637

Latest Updated Articles

Jannis Müller, MD, MSc (Credit: LinkedIn)
Published: May 14th 2025 | Updated: May 16th 2025
Observed Differences in PIRA Definition Call for More Standardized Agreement on Term
Giulia Fadda, MD (Credit: Ottawa Hospital Research Institute)
Published: May 12th 2025 | Updated: May 13th 2025
Serum Neurofilament Light Chain Limited in Predicting MOGAD Attacks but Correlates With Attack Severity
FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome
Published: March 27th 2025 | Updated: March 28th 2025
FDA Approves Diazoxide Choline Extended-Release Tablets for Hyperphagia in Prader-Willi Syndrome
BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts
Published: March 4th 2025 | Updated: March 19th 2025
BTK Inhibitor Tolebrutinib Shows Greater Effectiveness in Multiple Sclerosis with Higher Paramagnetic Rim Lesion Counts
FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management
Published: January 30th 2025 | Updated: February 21st 2025
FDA Approves Vertex Pharmaceuticals' Suzetrigine for Acute Pain Management
Cerebrospinal Fluid Lipids Shows Promise as Biomarkers for Differentiating NMOSD and MS
Published: February 15th 2025 | Updated: February 18th 2025
Cerebrospinal Fluid Lipids Shows Promise as Biomarkers for Differentiating NMOSD and MS
© 2025 MJH Life Sciences

All rights reserved.